Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations

Yang, Ying-Ying; Lin, Han-Chieh; Lee, Wui-Chiang; Hou, Ming-Chih; Lee, Fa-Yauh; Chang, Full-Young; Lee, Shou-Dong
March 2001
Journal of Gastroenterology;2001, Vol. 36 Issue 3, p181
Academic Journal
Abstract: Portopulmonary hypertension is now recognized as one of the pulmonary complications of chronic liver disease. However, previous studies reported that the incidence ranged from 0.25% to 2%, excluding fortuitous coincidence. In this study, we aimed to determine the variant hemodynamic and clinical features of portopulmonary hypertension in an area with a high prevalence of viral cirrhosis. After reviewing the hemodynamic data of 322 patients with portal hypertension admitted to the Taipei Veterans General Hospital between 1987 and 1999, we found 10 with portopulmonary hypertension. The overall incidence was, therefore, 3.1% in all patients with portal hypertension. Most of the patients with portopulmonary hypertension experienced exertional dyspnea. The survival times ranged from 2 to 86 months. In our series, most of the patients who died, died of complications related to cirrhosis and portal hypertension, but not of complications related to pulmonary hypertension. This study suggested that portopulmonary hypertension was not a frequent complication in cirrhotic patients and was not associated with an adverse outcome.


Related Articles

  • Hemodynamic Studies in Acute-on-Chronic Liver Failure. Ashish Kumar; Kunal Das; Praveen Sharma; Vimal Mehta; Barjesh Sharma // Digestive Diseases & Sciences;Apr2009, Vol. 54 Issue 4, p869 

    Abstract   Background Patients with decompensated cirrhosis and acute liver failure have circulatory dysfunctions leading to high portal pressure and cardiac output (CO) and low systemic vascular resistance (SVR). Circulatory changes in acute-on-chronic liver failure (ACLF) patients have...

  • INVESTIGATION OF HEPATIC BLOOD FLOW USING MICROBUBBLE ENHANCED ULTRASOUND IN THE DIAGNOSIS OF CIRRHOSIS. Anderloni, A.; MacQuarrie, J.; Leen, E.; Oein, K.; Angerson, W.J.; Morris, A.J. // Gut;Apr2003 Supplement 1, Vol. 52, pA3 

    Background: It has been previously shown that alterations in hepatic haemodynamics can be assessed in cirrhotic patients by measuring the hepatic vein transit time of an ultrasound contrast agent. Aim: To evaluate the clinical usefulness of a new contrast agent SonoVue, in differentiating...

  • Intraoperative pulmonary hypertension occurred in an asymptomatic patient with pre-existent liver cirrhotic and portal hypertension. Ling Lu; Feng Zhang; Xiang-Cheng Li; Guo-Qiang Li; Chuan-Yong Zhang; Xue-Hao Wang; Testro, Adam G. // World Journal of Gastroenterology;12/21/2008, Vol. 14 Issue 47, p7260 

    Portopulmonary hypertension (PPH) is clinically defined as the development of pulmonary arterial hypertension complicated by portal hypertension, with or without advanced hepatic disease. Physical signs may be absent in mild to moderate PPH and only appear in a hyperdynamic circulatory state....

  • Living-donor liver transplantation for moderate or severe porto-pulmonary hypertension accompanied by pulmonary arterial hypertension: a single-centre experience over 2 decades in Japan. Ogawa, Eri; Hori, Tomohide; Doi, Hiraku; Segawa, Hajime; Uemoto, Shinji // Journal of Hepato -- Biliary -- Pancreatic Sciences;Nov2012, Vol. 19 Issue 6, p638 

    Background: Candidates for orthotopic liver transplantation (OLT) often have porto-pulmonary hypertension (PPHTN) with pulmonary arterial hypertension (PAH). Poor outcomes of PPHTN contraindicate OLT. There are no guidelines for living-donor liver transplantation (LDLT) in PPHTN patients....

  • Sildenafil.  // Reactions Weekly;9/2/2006, Issue 1117, p21 

    The article discusses research on the use of sildenafil in treating a 37-year-old man's portopulmonary hypertension and hyperdynamic circulation. The patient had liver cirrhosis and oesophageal varices. It is thought that sildenafil has reduced elevated pulmonary arterial pressure in patients...

  • Vasodilators and Prostaglandin Inhibitors in Primary Pulmonary Hypertensions. Hermiller, James B.; Bambach, Dennis; Thompson, Michael J.; Huss, Patricia; Fontana, Mary E.; Magorien, Raymond D.; Unverferth, Donald V.; Leier, Carl V. // Annals of Internal Medicine;Oct82, Vol. 97 Issue 4, p480 

    Deals with a study which determined and compared the resting hemodynamic effects of various vasodilator agents and prostaglandin inhibitors in patients with primary pulmonary hypertension. Background on primary pulmonary hypertension; Patient population; Baseline hemodynamic data; Discussion...

  • Differential Effects of Terlipressin on Pulmonary and Systemic Hemodynamics in Patients With Cirrhosis and Pulmonary Hypertension: An Echo Study. Kalambokis, Georgios N.; Pappas, Konstantinos; Tsianos, Epameinondas V. // Angiology;Jun2012, Vol. 63 Issue 3, p199 

    Terlipressin has been associated with pulmonary arterial vasodilation in patients with pulmonary hypertension (PH). We investigated the effects of terlipressin on pulmonary vascular resistance (PVR) in patients with cirrhosis without and with PH. Pulmonary vascular resistance and cardiac output...

  • Evaluation of Rectal Mucosal Hemodynamics in Patients with Liver Cirrhosis Using Reflectance Spectrophotometry. Tezuha, Takashi; Akita, Yasushi; Yoshikawa, Nozomi; Mitamura, Keiji // American Journal of Gastroenterology (Springer Nature);Jun1997, Vol. 92 Issue 6, p1022 

    Objectives: Portal hypertensive colonopathy is observed in patients with liver cirrhosis. To determine the correlation between rectal mucosal hemodynamics and portal hypertensive colonopathy, we observed rectal mucosal findings and measured rectal mucosal hemodynamics in patients with liver...

  • Nitric Oxide May Contribute to Nocturnal Hemodynamic Changes in Cirrhotic Patients. Genesca, Joan; Segura, Rosa; Gonzalez, Antonio; Catalan, Robert; Marti, Ramon; Torregrosa, Mireia; Cereto, Ferran; Martinez, Moises; Esteban, Rafael; Guardia, Jaime // American Journal of Gastroenterology;Jun2000, Vol. 95 Issue 6, p1539 

    OBJECTIVE: Patients with liver cirrhosis have a nocturnal worsening of hemodynamic parameters that has been associated with an increased risk of variceal bleeding at night-time. The aim of this study was to investigate whether nitric oxide and cytokines are implicated in these hemodynamic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics